OrbiMed Capital GP III LLC, Director at AMARIN CORP PLC\UK (AMRN), sold 233,700 shares at $14.43 ($3.4M) on 2012-09-04, disclosed to the SEC on 2012-09-05.
Scheduled sale ($3.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.43 | 2,244 | $32K | 1.0% |
| 2 | $14.43 | 231,456 | $3.3M | 99.0% |
| Total | $14.43 avg | 233,700 | $3.4M | 100% |
| Filing → |
| VRAY | SELL | 2018-08-07 | $3.8M | — | Filing → |
| PIRS | SELL | 2018-02-15 | $141K | — | Filing → |
| PIRS | SELL | 2017-12-20 | $842K | — | Filing → |